Provided By GlobeNewswire
Last update: Nov 11, 2025
ST. LOUIS, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the third quarter ended September 30, 2025.
Read more at globenewswire.com2.24
-0.19 (-7.82%)
Find more stocks in the Stock Screener


